What approaches are used to mitigate lipemia interference in automated chemistry testing?

Prepare for the Clinical Chemistry Automation Test with a comprehensive practice quiz. Study with detailed explanations and multiple choice questions to enhance your understanding and boost your confidence. Ace your exam with our prepared material!

Multiple Choice

What approaches are used to mitigate lipemia interference in automated chemistry testing?

Lipemia interference arises from turbidity in the sample due to high lipid content, which can scatter light and distort optical measurements on automated chemistry analyzers. This can make results appear falsely high or low and compromise accuracy, so labs use a combination of strategies to ensure reliable results. First, lipemia clearing reagents can be used to reduce turbidity by treating or breaking down lipids, allowing the assay signal to be measured more accurately. Second, diluting the sample lowers the concentration of lipids, decreasing turbidity, though it also lowers the analyte signal and must be applied carefully. Third, using alternate assay methods helps when some methods are more susceptible to lipemia than others; a different detection principle or protocol can yield results with less interference. Finally, reporting lipemia indices with flagging alerts clinicians that the result may be affected by sample lipids and may require re-analysis or confirmation with an alternative method. Using these approaches together provides a comprehensive way to mitigate lipemia’s impact on results.

Lipemia interference arises from turbidity in the sample due to high lipid content, which can scatter light and distort optical measurements on automated chemistry analyzers. This can make results appear falsely high or low and compromise accuracy, so labs use a combination of strategies to ensure reliable results.

First, lipemia clearing reagents can be used to reduce turbidity by treating or breaking down lipids, allowing the assay signal to be measured more accurately. Second, diluting the sample lowers the concentration of lipids, decreasing turbidity, though it also lowers the analyte signal and must be applied carefully. Third, using alternate assay methods helps when some methods are more susceptible to lipemia than others; a different detection principle or protocol can yield results with less interference. Finally, reporting lipemia indices with flagging alerts clinicians that the result may be affected by sample lipids and may require re-analysis or confirmation with an alternative method.

Using these approaches together provides a comprehensive way to mitigate lipemia’s impact on results.

More practice questions